HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

HealthEquity, Inc. (NASDAQ:HQY) has received a consensus rating of “Moderate Buy” from the thirteen analysts that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $107.23.

A number of analysts have commented on the stock. BTIG Research upped their price target on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday. Barrington Research restated an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research report on Friday, September 20th. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. The Goldman Sachs Group assumed coverage on HealthEquity in a research note on Friday. They issued a “neutral” rating and a $108.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 13.10 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now directly owns 4,823 shares in the company, valued at $387,093.98. This represents a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Janney Montgomery Scott LLC grew its stake in HealthEquity by 27.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 3,970 shares of the company’s stock valued at $324,000 after purchasing an additional 855 shares during the period. US Bancorp DE increased its holdings in HealthEquity by 4.8% during the first quarter. US Bancorp DE now owns 11,489 shares of the company’s stock worth $938,000 after buying an additional 521 shares during the last quarter. ProShare Advisors LLC increased its holdings in HealthEquity by 5.7% during the first quarter. ProShare Advisors LLC now owns 19,477 shares of the company’s stock worth $1,590,000 after buying an additional 1,053 shares during the last quarter. State Board of Administration of Florida Retirement System raised its position in HealthEquity by 11.1% in the first quarter. State Board of Administration of Florida Retirement System now owns 26,663 shares of the company’s stock worth $2,177,000 after acquiring an additional 2,660 shares during the period. Finally, Pinnacle Wealth Planning Services Inc. purchased a new position in HealthEquity in the first quarter valued at about $264,000. 99.55% of the stock is owned by institutional investors.

HealthEquity Price Performance

Shares of HQY opened at $98.98 on Friday. The business has a 50-day moving average of $85.02 and a 200-day moving average of $81.07. HealthEquity has a 1 year low of $62.10 and a 1 year high of $101.17. The company has a market capitalization of $8.64 billion, a price-to-earnings ratio of 82.48, a price-to-earnings-growth ratio of 1.48 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. As a group, equities research analysts anticipate that HealthEquity will post 2.27 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.